Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.
18 employees · est. 2020 · San Diego, United States
Poseida Therapeutics, Inc.
A Member of the Roche Group
81 employees · est. 2014 · San Diego, United States
Poseida Therapeutics, Inc. is the older company (2020 vs 2014); Poseida Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Antharis Therapeutics, Inc. | Poseida Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2014 older |
| Headquarters | ||
| Headquarters | San Diego, United States | San Diego, United States |
| Employees | ||
| Employees | 18 | 81 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Acquired |
| Total Funding | ||
| Total Funding | Not tracked yet | $1.88B |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 9 |
| Services | ||
| Services | Developing Transformative Medicines, Therapies Harnessing the Immune System, Cutting-edge Biomedical Research, Therapeutically-relevant Antibody Development | Cell Therapy Development, Molecule Development, Patient Support Services, Clinical Trials Management, Scientific Research and Publications |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Patients with Unmet Medical Needs, Cancer Patients, Medical Institutions, Biotech and Pharmaceutical Partners | Patients, Medical Professionals, Pharmaceutical Partners, Scientists, Healthcare Media |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Cancer Treatment, Monoclonal Antibodies, Antibody-drug Conjugates, Oncology, Therapeutic Antibodies, Inflammatory Diseases, Innovative Therapies, Biotech Acquisitions, Clinical Trials, Transformational Therapies, Unmet Medical Needs, Pioneering Research, Solid Tumor Therapy, Bispecific Antibodies | Allogeneic Cell Therapies, Genetic Medicines, Genome Engineering, CAR-T Products, Gene Editing, Non-viral DNA Delivery, Site-Specific Gene Editing System, Chimeric Antigen Receptor, Immunotherapy, Regenerative Medicine, Hematological Malignancies, Solid Tumors, Proprietary Genetic Platforms, In-house GMP Manufacturing, Oncology |
| Website | ||
| Website | antharistherapeutics.com | poseida.com |
About Antharis Therapeutics, Inc.
Antharis Therapeutics, Inc., founded in 2020 by Dr. Raphael R Pinaud, is a multinational biopharmaceutical company headquartered in the United States. Specializing in cancer and inflammatory disease treatments, it employs cutting-edge science to create next-generation monoclonal antibodies and antib...
About Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc., now a Member of the Roche Group, is a clinical-stage biopharmaceutical company based in the United States. Initially founded in 2014, Poseida was acquired by Roche in early 2025, reinforcing its position in the biopharma and biotechnology industries. Pioneering in alloge...
We will tell you when either one moves
BounceWatch watches Antharis Therapeutics, Inc. and Poseida Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Antharis Therapeutics,... and Poseida Therapeutics,... — by email.
Frequently Asked Questions
Compare Antharis Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Antharis Therapeutics, Inc. on 27 Nov 2025, and Poseida Therapeutics, Inc. on 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
